Investors & Media

BRISBANE, Calif. --(BUSINESS WIRE)--Aug. 31, 2021-- Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that management will be participating in fireside chats at the following investor conferences: 2021 Virtual Wells Fargo Healthcare Conference Date: Friday,

BRISBANE, Calif. --(BUSINESS WIRE)--Aug. 9, 2021-- Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that management will participate in a fireside chat at the 2021 Wedbush PacGrow Healthcare Conference on Wednesday, August 11 th at 2:55pm Eastern Time .

Conference Call and Webcast Scheduled for 4:30 p.m. Eastern Time   BRISBANE, Calif. --(BUSINESS WIRE)--Aug. 5, 2021-- Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, today reported recent business highlights and second quarter 2021 financial results.

BRISBANE, Calif. --(BUSINESS WIRE)--Jul. 29, 2021-- Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that the Company has scheduled the release of its second quarter 2021 financial results after the market closes on Thursday, August 5, 2021 .

BRISBANE, Calif. --(BUSINESS WIRE)--May 24, 2021-- Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today the appointment of Prathyusha Duraibabu, CPA, MBA as Senior Vice President and Chief Financial Officer, effective June 1, 2021 . Ms.

BRISBANE, Calif. --(BUSINESS WIRE)--May 21, 2021-- Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that management will participate in a fireside chat at the Jefferies Healthcare Conference on Friday, June 4 th at 11am Eastern Time .

Conference Call and Webcast Scheduled for 5:00 p.m. Eastern Time   BRISBANE, Calif. --(BUSINESS WIRE)--May 4, 2021-- Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, today reported recent business highlights and first quarter 2021 financial results.

BRISBANE, Calif. --(BUSINESS WIRE)--May 3, 2021-- Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that management will be participating in fireside chats at the following investor conferences: BofA Securities 2021 Health Care Conference Date: Thursday, May 13

BRISBANE, Calif. --(BUSINESS WIRE)--Apr. 27, 2021-- Sangamo Therapeutics, Inc. (NASDAQ: SGMO), a genomic medicine company, today announced upcoming data presentations at the 24 th Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT) being held May 11-14, 2021 , in a virtual format.

BRISBANE, Calif. --(BUSINESS WIRE)--Apr. 27, 2021-- Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that the Company has scheduled the release of its first quarter 2021 financial results after the market closes on Tuesday, May 4, 2021 .